|
|
|
|
| LEADER |
00000cam a22000003 4500 |
| 001 |
in00000154711 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
151215nuuuuuuuuxx o 000 0 eng d |
| 005 |
20240701204901.5 |
| 019 |
|
|
|a 951065346
|
| 020 |
|
|
|a 1681081121
|q (electronic bk.)
|
| 020 |
|
|
|a 9781681081120
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)932263762
|z (OCoLC)951065346
|
| 035 |
|
|
|a (OCoLC)ocn932263762
|
| 040 |
|
|
|a YDXCP
|b eng
|e pn
|c YDXCP
|d EBLCP
|d OCLCQ
|d SFB
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCL
|d TMA
|d OCLCQ
|d SXB
|
| 050 |
|
4 |
|a RC684.E75
|b K65 2015
|
| 082 |
0 |
4 |
|a 616.12061
|q OCoLC
|2 23/eng/20230510
|
| 100 |
1 |
|
|a Author: Genovefa D. Kolovou.
|
| 245 |
1 |
0 |
|a Womens heart and estrogens.
|
| 260 |
|
|
|a [Place of publication not identified] :
|b Bentham Science Publisher
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a FOREWORD ; PREFACE ; Estrogens and Atherogenesis ; 1. INTRODUCTION; 2. ATHEROGENESIS; Cholesterol and Atherogenesis; 3. STAGES OF ATHEROGENESIS; 3.1. Initiation and Plaque Formation; Intimal Thickening, Fatty Streak Formation; Plaque Formation; Complicated Plaque; 3.2. Adaptation Stage; 3.3. Clinical Manifestation; 4. ESTROGENS AND STAGES OF ATHEROGENESIS; 5. ATHEROGENESIS -- PROMOTING FACTORS; 6. GENES INVOLVED IN ATHEROGENESIS IN YOUNG WOMEN; 6.1. Familial Hypercholesterolemia; 6.2. Sitosterolemia; 6.3. Apolipoprotein E Gene Polymorphisms.
|
| 505 |
8 |
|
|a 6.4. Cholesteryl Ester Transfer Protein Gene Polymorphisms6.5. Estrogen Receptor Gene Polymorphisms; DISCLOSURE; MAIN POINTS OF CHAPTER 1; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; Cardiovascular Actions of Estrogens ; 1. INTRODUCTION; 2. ESTROGENS BIOSYNTHESIS; 3. ACTIONS OF ESTROGENS; 4. CARDIOVASCULAR ACTIONS OF ESTROGENS; 4.1. Vasodilation Effects of Estrogens; 4.2. Anti-Inflammatory Effects of Estrogens; 4.3. Anti-Proliferative Effects of Estrogens; 4.4. Effects of Estrogens on Vascular Endothelium; 4.5. Women with Normal Endogenous Estrogens Concentration and Coronary Heart Disease.
|
| 505 |
8 |
|
|a 4.5.1. Vasculitis and Autoimmune Diseases4.5.2. Hypercoagulable States; 4.5.3. Non-Atherosclerotic Coronary Heart Disease; 4.5.4. Myocardial Infarction in Hallucinogenic Drug Abusers; 4.5.5. Atherosclerotic Coronary Heart Disease; 4.6. Pregnancy and Coronary Heart Disease; 5. ESTROGENS, LIPIDS AND LIPOPROTEINS CONCENTRATION; 5.1. Actions of Estrogens on Lipid Metabolism; 5.2. Fasting Lipids and Lipoproteins Concentration And Estrogens; 5.3. Nonfasting Triglycerides Concentration and Estrogens; 5.3.1. Postprandial Lipemia and Estrogens; 6. HEMATOLOGICAL FACTORS AND ESTROGENS.
|
| 505 |
8 |
|
|a 7. BODY COMPOSITION AND ESTROGENS8. ARTERIAL BLOOD PRESSURE AND ESTROGENS; 9. PLASMA GLUCOSE CONCENTRATION AND ESTROGENS; MAIN POINTS OF CHAPTER 2; CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; Menopause ; 1. INTRODUCTION; 2. MENOPAUSE AND CARDIOVASCULAR SYSTEM; 3. AGEING, MENOPAUSE AND ALTERNATIONS OF LIPID METABOLISM; 3.1. Ageing; 3.2. Menopause; 3.3. Menopause and Postprandial Hypertriglyceridemia; 4. HEMATOLOGIACAL FACTORS AND MENOPAUSE; 5. BODY COMPOSITION IN MENOPAUSAL WOMEN; 6. MENOPAUSE-RELATED ALTERATIONS IN BLOOD PRESSURE; 7. PLASMA GLUCOSE LEVELS IN MENOPAUSAL WOMEN.
|
| 505 |
8 |
|
|a MAIN POINTS OF CHAPTER 3CONFLICT OF INTEREST; ACKNOWLEDGEMENTS; Studies Evaluated Cardiovascular Events in Women Receiving Hormone Replacement Therapy ; 1. INTRODUCTION; 2. STUDIES EVALUATING CARDIOVASCULAR EVENTS IN WOMEN RECEIVING HORMONE REPLACEMENT THERAPY ; 2.1. Heart and Estrogen/Progestin Replacement Study (HERS), 1998 ; 2.1.1. HERS Study and Peripheral Arterial Disease, 2000; 2.1.2. HERS Study and Stroke, 2001; 2.1.3. HERS Study and Blood Glucose Levels, 2003; 2.1.4. HERS Study and Uric Acid Levels, 2006; 2.2. Estrogen Replacement and Atherosclerosis Trial (ERA), 2000.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Estrogen
|x Therapeutic use.
|
| 650 |
|
0 |
|a Heart diseases in women.
|
| 650 |
|
2 |
|a Estrogen Replacement Therapy
|
| 758 |
|
|
|i has work:
|a Womens heart and estrogens (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCYpvMWdJ3XxxRybH7Dj8JC
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Kolovou, Genovefa.
|t Women's Heart and Estrogens.
|d Sharjah : Bentham Science Publishers, ©2015
|z 9781681081137
|
| 852 |
|
|
|b E-Collections
|h ProQuest
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=4412588
|z Full text (MCPHS users only)
|t 0
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4412588
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12751600
|
| 947 |
|
|
|a FLO
|x pq-ebc-base
|
| 999 |
f |
f |
|s 871aa141-aa66-4f1c-90e2-4286978179d4
|i 980c56b4-c794-4c29-a113-42e8301da55c
|t 0
|
| 952 |
f |
f |
|a Massachusetts College of Pharmacy and Health Sciences
|b Online
|c Online
|d E-Collections
|t 0
|e ProQuest
|h Other scheme
|
| 856 |
4 |
0 |
|t 0
|u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=4412588
|y Full text (MCPHS users only)
|
